Akt as a Target in Cancer Research
Research has shown Akt expression promotes many processes associated with malignant phenotypes, demonstrating that Akt activation can be a precursor to cancer. Akt signaling has been targeted to better determine the effects of cancer therapies and learn more about the disease on a cellular level. Rockland’s Akt signaling antibodies are a crucial research tool and produce accurate, repeatable results in a variety of applications. To learn more, visit our website or contact us today.
This message has been sent and is copyright protected by Rockland Inc. 2013. All rights reserved.